Bristol-Myers Squibb | Umsatzkosten



Cost Of Sales Veränderung Datum
AbbVie USD 4.35B 344M 2025-06
Abbott USD 5.27B 834M 2025-06
ALKERMES USD 49.46M 263K 2025-06
Amgen USD 3.01B 406M 2025-06
AstraZeneca USD 2.47B 232M 2025-06
Biogen USD 605M 24.3M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Drreddys Laboratories INR 36.83B 2.29B 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
GlaxoSmithKline GBP 2.16B 241M 2025-06
J&J USD 7.6B 304M 2025-06
Medtronic USD 3.46B 346M 2025-07
Merck USD 2.82B 53M 2025-06
Novartis USD 3.32B 95M 2025-06
Novo Nordisk 12.85B 44M 2025-06
Perrigo USD 693.4M 41.8M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Prestige Brands USD 114.38M 12.13M 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.99B 103M 2025-06
Sanofi EUR 2.99B 721M 2025-06
United Therapeutics USD 175.2M 102.3M 2025-06
Zoetis USD 682M 60M 2025-06


Bristol-Myers Squibb Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.